EXCLUSIVE Interview with new COO of PASO

Patient Access Solutions, Inc. PASO

We’ve been focusing upon PASO this week, beginning on Monday with our PASO Special Report on the company that we suggest you read before proceeding any further!

As mentioned in that report, PASO recently issued a PR naming Dr. Donald Chiappetta the new Chief Operating Officer, in charge of day-to-day operations as well as the company’s long-term strategy moving forward. We also mentioned that we’d have the honor of speaking with Dr. Chiappetta this week, and that time has come.

We are very excited to present the EXCLUSIVE interview that we conducted Patient Access Solutions brand new executive, and learn more about this rapidly growing company straight from the source!

STT Interviews Dr. Donald Chiappetta, COO, Patient Access Solutions Inc. (PASO)

CLICK HERE
or on the graphic above to listen now!

We would strongly suggest that you subscribe to our YouTube channel so you don’t miss out on any future executive interviews conducted on our Stock Traders Talk website!


Extended Watchlist:
MBOT, GMNX, RBZ, CRZO, TMDI,

Blue Horseshoe Stocks: NFLX Review & More

Netflix, Inc. NFLX – Review

Nearly as often as we signal weekly options ideas, we also formulate longer term ones. Last month on the 12th, we entered our interest in the NFLX 01/25 $290-300 Calls into the log, and after an epic start to 2019, we’ve seen some really great moves.

NFLX stock alone, subsequent to our last alert, has traded for as little as 231.23 up to as high as yesterday’s new top mark of 357.22. That’s an incredible 54% jump in less than five weeks! What that move allowed our selected contracts to do has been nothing short of Earth-shattering.

$290 Calls – Range: 3.80-68.25 – Max Gain: 1696%
$292.50 Calls – Range: 3.28-49.22 – Max Gain: 1400%
$295 Calls – Range: 3.80-60.45 – Max Gain: 1491%
$297.50 Calls – Range: 3.47-59.76 – Max Gain: 1622%
$300 Calls – Range: 2.66-57.69 – Max Gain: 2069%
______

Fresh Options Ideas:
UAL Weekly $85-86 Calls
GT 03/01 $19-20 Calls


We also want to remind our readers to check out our PASO Report from Monday if you missed that, and stay tuned because we’ve got an exclusive interview with the company’s new Chief Operating Officer coming your way very soon!


Extended Watchlist:
PASO, HIPH, LXRX, GERN, TBLT, SCHW, TYME

Blue Horseshoe Stocks: TLRY Recap & More


Tilray, Inc. TLRY

Our first order of business this morning is to just provide a quick recap of our successful options idea from Friday, which we did not provide yesterday due to the release of our Special Report on PASO.(Check that report out if you missed it)

In Friday’s newsletter, we submitted the TLRY Weekly $92.50-95 Calls as potential day-trade candidates, and every single contract in that range provided huge multi-bag gain opportunities!

$92.50 Calls – Range: 2.10-8.30 – Max Gain: 295%
$93 Calls – Range: 2.00-9.20 – Max Gain: 360%
$93.50 Calls – Range: 1.80-5.00 – Max Gain: 178%
$94 Calls – Range: 2.14-9.83 – Max Gain: 359%
$95 Calls – Range: 1.21-8.85 – Max Gain: 631%


OPKO Health, Inc. OPK – Review

The last time we signaled OPK for observation was just a few weeks ago, on December 28th, just as the stock was gapping up off of its annual lows. Following that report, we’ve seen a couple weeks of steady gains, in an overall range from 2.84-3.935. That represents a solid 39% increase, and a good start to the 2019 calendar year.

We’ve also observed CEO Phillip Frost purchasing 15,000 shares out of the open market yesterday, near those highs. The next step for OPK would be to make a run at its 200DMA of 4.12, so we’ll continue to keep it on our radar in the days and weeks ahead.


Extended Watchlist:
PASO, DTEA, FTNW, KTOV, CVM